HABA LaboratoriesInc Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Noriko Koyanagi
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 0.6% |
| Management average tenure | no data |
| Board average tenure | 5.6yrs |
Recent management updates
Recent updates
What Type Of Returns Would HABA LaboratoriesInc's(TYO:4925) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Mar 09
These 4 Measures Indicate That HABA LaboratoriesInc (TYO:4925) Is Using Debt Reasonably Well
Feb 19Should You Be Impressed By HABA LaboratoriesInc's (TYO:4925) Returns on Capital?
Feb 01Is HABA Laboratories,Inc. (TYO:4925) A Smart Choice For Dividend Investors?
Jan 13
HABA Laboratories,Inc.'s (TYO:4925) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Dec 25What Kind Of Investors Own Most Of HABA Laboratories,Inc. (TYO:4925)?
Dec 07A Look At HABA LaboratoriesInc's (TYO:4925) Share Price Returns
Nov 19CEO
Noriko Koyanagi (79 yo)
less than a year
Tenure
Ms. Noriko Koyanagi is President of HABA Laboratories,Inc. since April 2024. She has been Adviser of HABA Co., Ltd.since March 2015. Ms. Koyanagi served as Factory Manager of HABA Co., Ltd. since Septembe...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman & President | 9.6yrs | no data | 0.58% ¥ 36.4m | |
| Director | 4.6yrs | no data | no data | |
| Independent Outside Director | 9.6yrs | no data | 0.56% ¥ 34.8m | |
| Independent Outside Director | 1.6yrs | no data | no data | |
| Director | 3.6yrs | no data | 0.026% ¥ 1.7m | |
| Independent Outside Director | 7.6yrs | no data | no data | |
| Independent Outside Director | 5.6yrs | no data | no data |
5.6yrs
Average Tenure
74yo
Average Age
Experienced Board: 4925's board of directors are considered experienced (5.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/03 01:54 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
HABA Laboratories,Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kenji Sakai | Mizuho Securities Co., Ltd. |